Autologous versus allogeneic mesenchymal stem cell therapy: The pros and cons

Surgery. 2022 May;171(5):1440-1442. doi: 10.1016/j.surg.2021.10.057. Epub 2021 Dec 1.

Authors

Nisha Durand¹, Abba C Zubair²

Affiliations

¹ Center for Regenerative Medicine and Department of Laboratory Medicine and Pathology, Mayo Clinic, Jacksonville, FL. Electronic address: durand.nisha@mayo.edu.
² Center for Regenerative Medicine and Department of Laboratory Medicine and Pathology, Mayo Clinic, Jacksonville, FL; Sheikh Shakhbout Medical City, Mayo Clinic Joint Venture, Abu Dhabi, UAE.

PMID: 34863523
DOI: 10.1016/j.surg.2021.10.057

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Hematopoietic Stem Cell Transplantation*
Humans
Mesenchymal Stem Cell Transplantation*
Mesenchymal Stem Cells*
Transplantation, Autologous